Community Home

communities_1.jpg

Announcements

  • Obstetrical Hematology Symposium 10/3/24

    By: Robert Sidonio Robert Sidonio , 21 days ago

    Dr. Malinowski will be hosting a Obstetrical Hematology Symposium on October 3rd. The link is below. See link below if interested?

    www.eventbrite.ca/e/914009054687

  • DOACs use in the treatment of antithrombin deficiency patients - the institutional approach - SURVEY

    By: Vera Ignjatovic Vera Ignjatovic , one month ago

    Following the completion of clinical studies which indicated that DOACs are effective and safe for prevention or treatment of VTE, these drugs became standard therapeutic treatment in patients with VTE. However, the use of DOACs has not been evaluated in 
    patients with severe thrombophilia, such as coagulation inhibitor deficiency, and therefore their safety and effectiveness in this setting remains unknown. In addition, plasma coagulation inhibitor deficiencies represent a rare form of thrombophilia, and hence research in this area is limited to individual cases or small retrospective studies.
    In order to advance the knowledge in this space, we are undertaking a project to determine whether DOACs are equally effective in the setting of various types of 
    antithrombin deficiency, as compared to the settings where these drugs have been formally studied.

    Please participate in this survey and contribute to advancing this field.

  • Public Comment Open: Guidance on laboratory detection & interpretation of aPL in APS

    By: Andrea Hickman Andrea Hickman , one month ago

    The Guidelines and Guidance (G&G) Committee requires a process for guidance manuscripts to go through a public comment period before approval to submit the manuscript to the Journal of Thrombosis and Haemostasis (JTH). The G&G Committee would like to announce that the guidance manuscript titled, "An update on laboratory detection and interpretation of antiphospholipid for diagnosis of antiphospholipid syndrome: Guidance from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies," is now open for public comment. Note: This manuscript is confidential and in draft form.

    Please submit your comments by Thursday, June 13, 2024.

    Kindly email Andrea Hickman at andrea_hickman@isth.org if you have any questions or concerns.

Latest Shared Files

Log in to see this information

Either the content you're seeking doesn't exist or it requires proper authentication before viewing.